Shijiazhuang Yiling Pharmaceutical Co., Ltd.

SZSE:002603.SZ

21.72 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008
Operating Activities:
Net Income 1,352.3792,356.8221,341.6321,214.931603.044592.955536.786535.926426.805354.495244.291185.806454.071315.026297.515122.252
Depreciation & Amortization 547.408451.469362.933268.162259.693253.162244.662216.838144.55685.54464.03261.19258.67548.98334.0529.731
Deferred Income Tax 104.482-158.70320.137-67.662-8.869-23.805-5.694.122-5.9450000000
Stock Based Compensation 0000000000000000
Change In Working Capital -1,865.572547.843-1,309.73324.786-856.498-760.391-659.679-138.031-443.121-341.468-264.615-189.935-940.981-61.055-20.55353.766
Accounts Receivables -700.492-831.659-1,280.279-668.731-800.368-823.026-456.143-255.471-328.285-52.853-171.345203.4490000
Inventory -459.668-348.014-104.738-364.915-40.847-105.39-148.022116.132-204.124-212.643-162.724-128.914-116.615-65.685-76.6187.127
Accounts Payables -722.7631,886.21955.1481,126.094-6.414131.219-49.82419.14395.2330000000
Other Working Capital 17.351-158.70320.137-67.662-8.869-655.002-511.657-254.163-238.997-128.825-101.891-61.021-824.3664.6356.06546.639
Other Non Cash Items 3,032.334131.603133.86278.29462.686-13.359-7.11616.9093.6377.33311.61413.06419.749-3.2367.1994.429
Operating Cash Flow 193.2923,487.736528.6941,586.17368.92572.367114.653631.642131.878105.90455.32270.129-408.486299.718318.211210.178
Investing Activities:
Investments In Property Plant And Equipment -310.834-213.98-673.559-1,144.779-454.428-187.228-180.348-373.027-478.434-450.192-409.828-296.889-177.896-285.018-210.57-128.27
Acquisitions Net -675.3190.3512.3731,145.087.1230-1.747373.192478.513450.558409.86100-25.55100
Purchases Of Investments -3,638.122-3,461.873-451.047-2,853.315-2,114.796-1,374.786-1,756.5-247.149-89.251-1,500.783-1,21000287.78500
Sales Maturities Of Investments 3,687.2231,680.702616.6492,957.5962,598.9761,599.735984.979115.066462.6091,596.861733.859000.64900
Other Investing Activites 87.9010-1.175-1,144.7790.2478.6451.071-373.027-478.434-450.192-409.8280.2020.013-285.018-210.570.193
Investing Cash Flow -937.052-1,994.801-506.759-1,040.19837.12146.366-952.546-504.945-104.997-353.748-885.936-296.687-177.883-307.153-210.57-128.077
Financing Activities:
Debt Repayment -549.7-2,200.009-1,469.929-269.98-500-100-50-600-47-251-2610-110-30
Common Stock Issued 000049.95700000000000
Common Stock Repurchased 0000-99.957-500000000000
Dividends Paid -835.353-282.702-1,193.361-238.672-119.776-120.631-103.061-86.856-58.359-55.24-56.053-35.911-56.1-4.811-1.935-83.738
Other Financing Activities 69.5811,845.712,387.913490.81750.209-23.2211,295.807113.52120.761-5.07144.213502,462.844204.5028994.5
Financing Cash Flow -220.595-637.001-302.145-23.26-169.588-143.8521,092.746-23.3362.401-60.30941.16-236.9112,145.744199.69-22.935-19.238
Other Information:
Effect Of Forex Changes On Cash 0.3261.248-0.481-1.953-0.6350.027-0.2410.108-0.2270.0540.0310.0280.032-000
Net Change In Cash -963.764857.183-280.692520.761-64.176-25.092254.612103.46929.055-308.1-789.423-463.4421,559.408192.25584.70662.862
Cash At End Of Period 940.5121,810.663953.4811,234.172713.411777.587802.679534.059430.59401.535709.6351,499.0571,962.499403.091210.836126.13